Evaluating High Fluorescence Lymphocyte Count as a Predictor of Severe Dengue Infection
Journal of Clinical Laboratory Analysis · 2025-09 · 39 (17)
DOI: 10.1002/jcla.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 28.07.2025. Verfasst von Anh Vu Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Military Hospital 103, Vietnam. Hauptthemen laut MEDLINE: Severe Dengue, Dengue. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Dengue infection (DI) is a significant global health concern, with severe cases leading to plasma leakage, organ failure, and shock. Identifying reliable biomarkers for early risk stratification is crucial for improving patient management.
Methods
This descriptive cross‐sectional study included 268 DI patients at 103 Military Hospital, Vietnam, from July 2022 to October 2023. Patients were classified into Non‐Severe DI and Severe DI groups per the 2009 WHO dengue guideline. High Fluorescent Lymphocyte Count (HFLC), a parameter from the Sysmex hematology analyzer, was analyzed. HFLC% represents the proportion of high fluorescent lymphocytes among total WBCs, while HFLC# is these cells' absolute count (G/L). Statistical methods included Mann–Whitney U, Kruskal‐Wallis, Chi‐square tests, ROC curve analysis, and binary logistic regression.
Results
HFLC% and HFLC# were significantly elevated in Severe DI compared to Non‐Severe DI ( p < 0.001). HFLC% negatively correlated with platelet count and positively with liver enzymes (AST, ALT), suggesting an association with severe complications. ROC analysis showed that HFLC# (AUC = 0.913, p < 0.001, cut‐off = 1.00 G/L) had 70.6% sensitivity and 90.8% specificity, while HFLC% (AUC = 0.833, p < 0.001, cut‐off = 13.15%) had 70.6% sensitivity and 80.5% specificity for predicting severe DI.
Conclusion
Elevated HFLC at admission is strongly associated with severe DI, with HFLC# demonstrating excellent predictive accuracy. These findings suggest that HFLC is a promising biomarker for early identification of high‐risk dengue patients. Further large‐scale validation is required to confirm its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Military Hospital 103, Vietnam.
- Vietnam Military Medical University, Vietnam.
ORCID-Profile: Kien Nguyen Trung, Hanh Nguyen Thi Hien, Hung Ta Viet
Zitieren
APA
Hong, A. V., Nguyen Trung, K., Nguyen Thi Hien, H., & Ta Viet, H. (2025). Evaluating High Fluorescence Lymphocyte Count as a Predictor of Severe Dengue Infection. Journal of Clinical Laboratory Analysis, 39(17). https://doi.org/10.1002/jcla.70083
Vancouver
Hong AV, Nguyen Trung K, Nguyen Thi Hien H, Ta Viet H. Evaluating High Fluorescence Lymphocyte Count as a Predictor of Severe Dengue Infection. Journal of Clinical Laboratory Analysis. 2025;39(17). doi:10.1002/jcla.70083
BibTeX
@article{Hong2025,
author = {Hong, Anh Vu and Nguyen Trung, Kien and Nguyen Thi Hien, Hanh and Ta Viet, Hung},
title = {Evaluating High Fluorescence Lymphocyte Count as a Predictor of Severe Dengue Infection},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
volume = {39},
number = {17},
doi = {10.1002/jcla.70083}
}
EUVIMED